by Joe Hartman | Aug 27, 2014 | Neuromonitoring Training
The G0453 Code ATTENTION: This Needs To Be Handled By 9/2/2014 (EDIT: Action time is over to kill the G0453, but still worth the read) Neuromonitoring professionals have been waiting to see how Medicare’s new G code (G0453) is going to affect the way we deliver our...
by Joe Hartman | Oct 30, 2013 | Neuromonitoring Training
Muscle Relaxants And Neurophysiological Monitoring So you want to tell anesthesia they can’t use muscle relaxant on this case? You’re bound to get a wide ranges of responses, from acknowledgement, dirty looks and maybe even a full blown temper tantrum....
by Joe Hartman | Jul 30, 2013 | Neuromonitoring Training
Direct Motor Evoked Potentials Continuing on from the post about intraoperative monitoring for gliomas (and trying my best not to ramble on too much in this post), I’d like to discuss some pros and cons to using a surface electrode strip as an anode directly on...
by Joe Hartman | Jul 25, 2013 | Neuromonitoring Training
Neurophysiologic Intraoperative Monitoring With Sugammadex Let me start off by saying this… I have no experience with the use of Sugammadex during neurophysiological monitoring. The drug was denied FDA clearance in the USA in 2008, so maybe some UK readers can...
by Joe Hartman | Jul 15, 2013 | Neuromonitoring Training
Somatosensory Evoked Potential Test Variability In my previous 2 post about temporal dispersion and somatosensory evoked potential test variability, I went over how to ID trial-to-trial variability, how to handle it and what was happening to the waveform. I’m...
by Joe Hartman | Jul 8, 2013 | Neuromonitoring Training
SSEP Increased Variability vs. Increased Latency: A question from a reader… In my last post, I talked about using the waterfall function to better determine your SSEP baselines, as well as how using it can be helpful in determining your level of confidence with...